	Prognostic value of carcinoembryonic antigen kinetics in predicting distant metastatic recurrence of breast cancer: a multicenter cohort study. Ann Surg Treat Res Kim BK, Kim D, Baek JM, Eom YH, Kang YJ, Rhu J, Ahn J, Jeon YW, Sun WY. PMID: 42131423 [PubMed]
	Predicting response to neoadjuvant therapy in breast cancer using longitudinal DCE-MRI deep learning integrated with tumor microenvironment data. Front Immunol Yan L, Huang X, Liu L, Wu A, Luo Y, Li H, Yi S, Yu T, Zeng Q. PMID: 42131346 [PubMed - indexed for MEDLINE]
	Public health determinants of screening accessibility, diagnostic and treatment timeliness, care adherence, and survival outcomes in breast cancer patients. Front Public Health Zhang M, Pang H, Cheng B, Deng J, Guo W. PMID: 42130874 [PubMed - indexed for MEDLINE]
	Twelve-year trends in cervical cytology screening: a retrospective analysis of 83,148 smears from a Turkish tertiary care center. Front Public Health Guzelbag B, Uzuner EG, Selcuk M, Ermin S, Ozgun Selcuk CG, Cim N. PMID: 42130867 [PubMed - indexed for MEDLINE]
	Redox-endocrine triad in PCOS: can vitamin D, myo-inositol, and melatonin synergize as bioactive cocktails? Front Endocrinol (Lausanne) Subakathulla S, Manoj N, Patanwala AM, Premvignesh PA, Maher Alobaid Y, Majie A, Gorain B, Dutta S, Sengupta P, Rosas IM, Roychoudhury S. PMID: 42130739 [PubMed - indexed for MEDLINE]
	KRAS Gene Variants rs712 and rs61764370 as Predictive Markers of Breast Cancer Susceptibility in a Bangladeshi Population: A Case-Control Study. Health Sci Rep Eva TA, Miti MMT, Nisha NZ, Tasnim Z, Saha T, Khan M, Moon NT, Haque MA. PMID: 42130643 [PubMed]
	Diagnostic value of [(18)F]AlF-NOTA-FAPI-04 PET/CT in breast cancer: comparison with conventional imaging. Front Oncol Liu J, Pang Y, Liu T, Xu S, Pei J, Wang S, Guo Y, Wang J, Yu J, Li W, Liu J. PMID: 42130640 [PubMed]
	Not all masses are metastases: a diagnostic dilemma resolved - synchronous HER2-positive breast cancer and renal oncocytoma. Int J Surg Case Rep Shrivastava N, Mitra S, Pande S. PMID: 42130550 [PubMed]
	Test-time adaptation-driven patient-specific auto-segmentation for CBCT-guided online adaptive radiotherapy in cervical cancer. J Appl Clin Med Phys Wang Z, Zhang W, Meng X, Liang Y, Dong T, Zhang J, Liu N, Yu L, Yang B, Zhou Q, Qiu J. PMID: 42130279 [PubMed - indexed for MEDLINE]
	Age, patient experience and satisfaction with breast cancer care: a cohort study using linked national cancer patient experience survey and cancer registry data. BMJ Open Blacker S, Withrow DR, Boyle JM, Wang L, Delon C, Medina J, Horgan K, Dodwell D, Verrill M, Lemanska A, Frampton AE, Cromwell DA. PMID: 42130004 [PubMed - indexed for MEDLINE]
	PEM as an adjunct to MRI or CESM for characterizing non-mass enhancement: a retrospective two-arm diagnostic study. Cancer Imaging Mohamed NEEA, Elmesidy D, Rahman RWA, Ahmed ARO, Ibraheem MH, Salam GMA, Sobhi A. PMID: 42129947 [PubMed - indexed for MEDLINE]
	Progress of estrogen receptor and splice variants in ovarian carcinoma. J Ovarian Res Mo T, Hong Z, Mo Y, Tian J, Chen J. PMID: 42129836 [PubMed - as supplied by publisher]
	The adipogenesis-related gene CEBPD as a prognostic biomarker and functional tumor suppressor in breast cancer. Cell Div Qiu S, Chen X, Yang J, Sun Y, Liu Y, Wu D, Sun J. PMID: 42129818 [PubMed - as supplied by publisher]
	MRI-based habitat and peritumoral radiomics for predicting HER2 status in breast cancer: a multicenter study. Sci Rep Luo W, Li B, Wang H, Lu Z, Liu Z, Zhang Y, Chen Y, Xue Z, Nong S, Ke Y, Wang L, Li X. PMID: 42129487 [PubMed - as supplied by publisher]
	Diabetes mellitus and health-related quality of life in long-term survivors of breast, colorectal or prostate cancer: a population-based prospective study. Br J Cancer Yang K, Thong MSY, Doege D, Koch-Gallenkamp L, Weisser L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Jansen L, Brenner H, Arndt V. PMID: 42129336 [PubMed - as supplied by publisher]
	Metaheuristic optimization of deep CNNs for multi-class diagnosis of cervical cancer and lymphoma. Sci Rep Abdelhay EH, Elgamily KM, Badr WOE. PMID: 42129228 [PubMed - indexed for MEDLINE]
	Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial. Nat Commun Veneziani AC, Lheureux S, Millar DG, Dhani N, Colombo I, Madariaga A, Soberanis Pina P, Atale S, Chan YL, Lee J, Ramsahai J, Quintos J, Wang L, Li X, Bowering V, Ohashi P, Wang B, Oza AM. PMID: 42129168 [PubMed - as supplied by publisher]
	Providing information to prepare breast cancer patients for their surgical consultation: barriers and recommendations (an analysis from Alliance A231701CD). Support Care Cancer Saucke MC, Jacobson N, Chow S, McKinney G, Neuman HB. PMID: 42128956 [PubMed - indexed for MEDLINE]
	Mucinous carcinoma of the breast: morphological spectrum, diagnostic pitfalls and classification challenges. J Clin Pathol Rakha EA, Wazwaz B, Fox SB. PMID: 42128624 [PubMed - as supplied by publisher]
	Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10). BMJ Open Ozaki Y, Koyama S, Morita S, Miyashita M, Tokuda E, Shimoi T, Fukuoka M, Masuda H, Takano Y, Shibata N, Yoshinami T, Murakami A, Tamaki K, Ishiguro H, Saji S, Miwa A, Matsunaga J, Zheng Y, Nishikawa H, Masuda N. PMID: 42128502 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 328636

Page 1 of 16432



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy